Catasys provides a holistic solution for the most expensive "treatment-avoidant" plan member population, integrating cutting-edge technology with personalized human engagement.
FY 2019 revenues are forecast to rise over 130% YOY as it enters the hyper-growth stage with its healthcare cost-shrinking model versus the traditional cost-growing income model.
Its proprietary evidence-based outpatient “OnTrak” 52-week program boasts 54% cost-savings to insurers with a 78% success rate for patients.
it is contracted with 7 of the top 8 largest health insurers covering over 100-million members.
Catasys is gamechanger at the apex where value-based reimbursement and evidence-based treatment models converge to disrupt the Behavioral Health industry.
Editor's note: Seeking Alpha is proud to welcome Katie Mikles as a new contributor. It's easy to become a Seeking Alpha contributor and earn money for your best investment ideas. Active contributors also get free